Singh Shawn bought VTGN
April 7, 2026 · Form 4 insider transaction
Singh Shawn bought 3,732 shares of Vistagen Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,732
Price
$0.00
Total value
N/A
InsiderSingh Shawn
RoleOfficer, Director
SecurityIncentive Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 7, 2026
Filing dateApril 9, 2026
Shares owned after3,732
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date.